That cup of joe to start your day may be more important than you realize. 

Regularly consuming moderate amounts of caffeine may offer a protective effect against developing multiple cardiometabolic diseases, according to a new study. Cardiometabolic diseases include type 2 diabetes, coronary heart disease, and stroke.

“Consuming three cups of coffee, or 200-300 mg caffeine, per day might help to reduce the risk of developing cardiometabolic multimorbidity in individuals without any cardiometabolic disease,” said the study’s lead author, Dr. Chaofu Ke from the Department of Epidemiology and Biostatistics, School of Public Health at Suzhou Medical College of Soochow University, in Suzhou, China, in a press release. “The findings highlight that promoting moderate amounts of coffee or caffeine intake as a dietary habit to healthy people might have far-reaching benefits for the prevention of [cardiometabolic multimorbidity].”

The prevalence of individuals with multiple cardiometabolic diseases is becoming an increasing public health concern, according to the study.

CLICK HERE TO GET THE DALLAS EXPRESS APP

CNN details the study’s findings, which will surely have coffee drinkers rejoicing. Here’s the start of the story:

A morning cup of coffee may do more than just perk you up, according to new research.

Moderate amounts of caffeine intake — defined as about three cups of coffee or tea a day — were associated with a lower risk of developing cardiometabolic multimorbidity, said the study’s lead author, Dr. Chaofu Ke, associate professor of epidemiology and biostatistics at Soochow University in Suzhou, China.

Cardiometabolic multimorbidity, or CM, is the coexistence of at least two cardiometabolic diseases such as coronary heart disease, stroke and type 2 diabetes.

“Coffee and caffeine consumption may play an important protective role in almost all phases of CM development,” Ke said.

Researchers analyzed data from about 180,000 people in the UK Biobank, a large biomedical database and research resource that follows people long-term. Those involved did not have cardiometabolic diseases at the outset.

The information included the participants’ self-reported caffeine consumption through coffee or black or greentea and the cardiometabolic diseases they developed through their primary care data, hospital records and death certificates, according to the study published Tuesday in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.